BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31562209)

  • 21. Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT.
    Kojima R; Kajikawa M; Shiroishi M; Kuroki K; Maenaka K
    J Mol Biol; 2011 Nov; 413(4):762-72. PubMed ID: 21959263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory role of BTLA and HVEM checkpoint inhibitors in T cell activation in a perciform fish Larimichthys crocea.
    Jin CY; Su N; Hu CB; Shao T; Ji JF; Qin LL; Fan DD; Lin AF; Xiang LX; Shao JZ
    Dev Comp Immunol; 2022 Mar; 128():104312. PubMed ID: 34767880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BTLA inhibition has a dominant role in the
    Battin C; Leitner J; Waidhofer-Söllner P; Grabmeier-Pfistershammer K; Olive D; Steinberger P
    Front Immunol; 2022; 13():956694. PubMed ID: 36081508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection.
    Yu X; Zheng Y; Mao R; Su Z; Zhang J
    Front Immunol; 2019; 10():617. PubMed ID: 30984188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells.
    Tao R; Wang L; Murphy KM; Fraser CC; Hancock WW
    J Immunol; 2008 May; 180(10):6649-55. PubMed ID: 18453584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sirolimus-based regimen promotes inhibitory costimulatory signal of HVEM/BTLA/CD160/LIGHT pathway in allo-renal recipients.
    Bai Y; Shi Y; Li Y; Cai B; Zou Y; Wang L
    Transpl Immunol; 2013 Jan; 28(1):38-47. PubMed ID: 23165214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Expression of BTLA Was Increased and the Expression of HVEM and LIGHT Were Decreased in the T Cells of Patients with Rheumatoid Arthritis [corrected].
    Yang B; Huang Z; Feng W; Wei W; Zhang J; Liao Y; Li L; Liu X; Wu Z; Cai B; Bai Y; Wang L
    PLoS One; 2016; 11(5):e0155345. PubMed ID: 27183113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes Simplex Virus 1 Latency and the Kinetics of Reactivation Are Regulated by a Complex Network of Interactions between the Herpesvirus Entry Mediator, Its Ligands (gD, BTLA, LIGHT, and CD160), and the Latency-Associated Transcript.
    Wang S; Ljubimov AV; Jin L; Pfeffer K; Kronenberg M; Ghiasi H
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30282707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation.
    Cai G; Freeman GJ
    Immunol Rev; 2009 May; 229(1):244-58. PubMed ID: 19426226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cells.
    Gertner-Dardenne J; Fauriat C; Orlanducci F; Thibult ML; Pastor S; Fitzgibbon J; Bouabdallah R; Xerri L; Olive D
    Blood; 2013 Aug; 122(6):922-31. PubMed ID: 23692853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM.
    Murphy TL; Murphy KM
    Annu Rev Immunol; 2010; 28():389-411. PubMed ID: 20307212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.
    Cheung TC; Oborne LM; Steinberg MW; Macauley MG; Fukuyama S; Sanjo H; D'Souza C; Norris PS; Pfeffer K; Murphy KM; Kronenberg M; Spear PG; Ware CF
    J Immunol; 2009 Dec; 183(11):7286-96. PubMed ID: 19915044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.
    Sedy JR; Gavrieli M; Potter KG; Hurchla MA; Lindsley RC; Hildner K; Scheu S; Pfeffer K; Ware CF; Murphy TL; Murphy KM
    Nat Immunol; 2005 Jan; 6(1):90-8. PubMed ID: 15568026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction.
    del Rio ML; Jones ND; Buhler L; Norris P; Shintani Y; Ware CF; Rodriguez-Barbosa JI
    J Immunol; 2012 May; 188(10):4885-96. PubMed ID: 22490863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses.
    Spodzieja M; Lach S; Iwaszkiewicz J; Cesson V; Kalejta K; Olive D; Michielin O; Speiser DE; Zoete V; Derré L; Rodziewicz-Motowidło S
    PLoS One; 2017; 12(6):e0179201. PubMed ID: 28594868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic expansion of virus-specific CD8
    Wang H; Wu B; Li L; Hu L; Lin J; Jiang C; Cai G; Shen Q
    Cell Immunol; 2017 Jan; 311():36-45. PubMed ID: 27743606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fragments of gD Protein as Inhibitors of BTLA/HVEM Complex Formation-Design, Synthesis, and Cellular Studies.
    Kuncewicz K; Battin C; Sieradzan A; Karczyńska A; Orlikowska M; Wardowska A; Pikuła M; Steinberger P; Rodziewicz-Motowidło S; Spodzieja M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex.
    Compaan DM; Gonzalez LC; Tom I; Loyet KM; Eaton D; Hymowitz SG
    J Biol Chem; 2005 Nov; 280(47):39553-61. PubMed ID: 16169851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphtoxin beta receptor-Ig protects from T-cell-mediated liver injury in mice through blocking LIGHT/HVEM signaling.
    An MM; Fan KX; Cao YB; Shen H; Zhang JD; Lu L; Gao PH; Jiang YY
    Biol Pharm Bull; 2006 Oct; 29(10):2025-30. PubMed ID: 17015945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The BTLA-HVEM axis restricts CAR T cell efficacy in cancer.
    Guruprasad P; Carturan A; Zhang Y; Cho JH; Kumashie KG; Patel RP; Kim KH; Lee JS; Lee Y; Kim JH; Chung J; Joshi A; Cohen I; Shestov M; Ghilardi G; Harris J; Pajarillo R; Angelos M; Lee YG; Liu S; Rodriguez J; Wang M; Ballard HJ; Gupta A; Ugwuanyi OH; Hong SJA; Bochi-Layec AC; Sauter CT; Chen L; Paruzzo L; Kammerman S; Shestova O; Liu D; Vella LA; Schuster SJ; Svoboda J; Porazzi P; Ruella M
    Nat Immunol; 2024 Jun; 25(6):1020-1032. PubMed ID: 38831106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.